Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
902.2500
-0.15
(
-0.02
%)
NSE
Feb 20, 2026
13:26 PM
Volume:
359.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
22 Mar 2023
US FDA Approval
902.25
-0.02%
Zydus Life
Buy:
Zydus Lifesciences Ltd.
by
Sharekhan
Target: 572
Target
Sharekhan
Prabhudas Lilladhar released a Accumulate report for Zydus Lifesciences Ltd. with a price target of 1020.0 on 11 Feb, 2026.
More from Zydus Lifesciences Ltd.
Recommended
Market trades higher, Bajaj Finserv’s arm to raise up to $1 billion for expansion
Trendlyne Marketwatch |
20 Feb 2026, 01:24PM
3 picks: Capex plans and big dreams for three electronics players
The Baseline |
19 Feb 2026, 12:25PM
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020